These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 24385451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M, Plens K, Wojtowicz W, Undas A.
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA, D-dimer Optimal Duration Study Investigators.
    Ann Intern Med; 2015 Jan 06; 162(1):27-34. PubMed ID: 25560712
    [Abstract] [Full Text] [Related]

  • 9. Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
    Tullett J, Murray E, Nichols L, Holder R, Lester W, Rose P, Hobbs FD, Fitzmaurice D.
    BMC Cardiovasc Disord; 2013 Mar 09; 13():16. PubMed ID: 23497371
    [Abstract] [Full Text] [Related]

  • 10. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.
    Poli D, Cenci C, Antonucci E, Grifoni E, Arcangeli C, Prisco D, Abbate R, Miniati M.
    Thromb Haemost; 2013 Feb 09; 109(2):181-6. PubMed ID: 23196319
    [Abstract] [Full Text] [Related]

  • 11. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E, Johnsen HS, Hansen JB, Braekkan SK.
    J Thromb Haemost; 2017 May 09; 15(5):917-924. PubMed ID: 28166605
    [Abstract] [Full Text] [Related]

  • 12. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, Poli D, Lim W.
    Ann Intern Med; 2008 Oct 07; 149(7):481-90, W94. PubMed ID: 18838728
    [Abstract] [Full Text] [Related]

  • 13. D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
    Steinbrecher O, Šinkovec H, Eischer L, Kyrle PA, Eichinger S.
    Thromb Res; 2021 Jan 07; 197():160-164. PubMed ID: 33220565
    [Abstract] [Full Text] [Related]

  • 14. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F, Prager G, Thaler J, Posch F, Wiedemann S, Schramm T, Englisch C, Mackman N, Pabinger I, Ay C.
    Arterioscler Thromb Vasc Biol; 2021 Nov 07; 41(11):2837-2847. PubMed ID: 34470475
    [Abstract] [Full Text] [Related]

  • 15. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
    Eichinger S, Heinze G, Jandeck LM, Kyrle PA.
    Circulation; 2010 Apr 13; 121(14):1630-6. PubMed ID: 20351233
    [Abstract] [Full Text] [Related]

  • 16. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P, Barbar S, Milan M, Campello E, Spiezia L, Piovella C, Pesavento R.
    Thromb Haemost; 2015 Jun 13; 113(6):1210-5. PubMed ID: 25119194
    [Abstract] [Full Text] [Related]

  • 17. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
    Kyrle PA, Eischer L.
    Hamostaseologie; 2013 Aug 01; 33(3):201-9. PubMed ID: 23712242
    [Abstract] [Full Text] [Related]

  • 18. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.
    Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P, DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators.
    Blood; 2014 Jul 10; 124(2):196-203. PubMed ID: 24879813
    [Abstract] [Full Text] [Related]

  • 19. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 10; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 20. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P, Vedovetto V, Ciammaichella M, Bucherini E, Corradini S, Enea I, Cosmi B, Mumoli N, Visonà A, Barillari G, Bova C, Quintavalla R, Zanatta N, Pedrini S, Villalta S, Camporese G, Testa S, Parisi R, Becattini C, Cuppini S, Pengo V, Palareti G, Morgagni Investigators.
    Thromb Res; 2017 Jun 10; 154():35-41. PubMed ID: 28407492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.